- Home
- SPRY vs GAM Comparison
SPRY vs GAM Comparison
Compare SPRY & GAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRY
- GAM
- Stock Information
- Founded
- SPRY 2015
- GAM 1927
- Country
- SPRY United States
- GAM United States
- Employees
- SPRY N/A
- GAM N/A
- Industry
- SPRY Biotechnology: Pharmaceutical Preparations
- GAM Investment Managers
- Sector
- SPRY Health Care
- GAM Finance
- Exchange
- SPRY Nasdaq
- GAM Nasdaq
- Market Cap
- SPRY 1.2B
- GAM 1.2B
- IPO Year
- SPRY N/A
- GAM N/A
- Fundamental
- Price
- SPRY $12.60
- GAM $50.25
- Analyst Decision
- SPRY Strong Buy
- GAM
- Analyst Count
- SPRY 4
- GAM 0
- Target Price
- SPRY $28.75
- GAM N/A
- AVG Volume (30 Days)
- SPRY 2.0M
- GAM 20.1K
- Earning Date
- SPRY 03-20-2025
- GAM 01-01-0001
- Dividend Yield
- SPRY N/A
- GAM 5.74%
- EPS Growth
- SPRY N/A
- GAM N/A
- EPS
- SPRY 0.08
- GAM 11.67
- Revenue
- SPRY $89,149,000.00
- GAM N/A
- Revenue This Year
- SPRY $41.49
- GAM N/A
- Revenue Next Year
- SPRY $80.23
- GAM N/A
- P/E Ratio
- SPRY $156.13
- GAM $3.95
- Revenue Growth
- SPRY 297063.34
- GAM N/A
- 52 Week Low
- SPRY $7.55
- GAM $37.32
- 52 Week High
- SPRY $18.51
- GAM $46.48
- Technical
- Relative Strength Index (RSI)
- SPRY 53.51
- GAM 43.67
- Support Level
- SPRY $12.08
- GAM $50.08
- Resistance Level
- SPRY $13.22
- GAM $51.53
- Average True Range (ATR)
- SPRY 0.91
- GAM 0.58
- MACD
- SPRY 0.12
- GAM 0.10
- Stochastic Oscillator
- SPRY 41.07
- GAM 47.25
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About GAM General American Investors Inc.
General American Investors Co Inc is a closed-end, diversified management investment company. The primary investment objective of the company is long-term capital appreciation through investment in companies with above-average growth potential. It focuses on equity securities with growth potential at reasonable valuations.